Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg)

Background: First-line Helicobacter pylori (H. pylori) treatments have been relatively well evaluated; however, it remains necessary to identify the most effective rescue treatments. Our aim was to assess the effectiveness and safety of H. pylori regimens containing rifabutin. METHODS: International...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyssen, Olga P., Vaira, Dino, Saracino, Ilaria Maria, Fiorini, Giulia, Caldas, María, Bujanda, Luis, Pellicano, Rinaldo, Keco-Huerga, Alma, Pabón-Carrasco, Manuel, Oblitas Susanibar, Elida, Di Leo, Alfredo, Losurdo, Giuseppe, Pérez-Aísa, Ángeles, Gasbarrini, Antonio, Boltin, Doron, Smith, Sinead, Phull, Perminder, Rokkas, Theodore, Lamarque, Dominique, Cano-Català, Anna, Puig, Ignasi, Mégraud, Francis, O’Morain, Colm, Gisbert, Javier P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949410/
https://www.ncbi.nlm.nih.gov/pubmed/35329984
http://dx.doi.org/10.3390/jcm11061658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949410/
https://www.ncbi.nlm.nih.gov/pubmed/35329984
http://dx.doi.org/10.3390/jcm11061658

Ejemplares similares